Urological Cancer Therapeutics Drugs Market - Global Outlook and Forecast 2024-2031

Report ID: 831049 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Urological Cancer Therapeutics Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Urological Cancer Therapeutics Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Urological Cancer Therapeutics Drugs Overall Market Size
    2.1 Global Urological Cancer Therapeutics Drugs Market Size: 2021 VS 2027
    2.2 Global Urological Cancer Therapeutics Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Urological Cancer Therapeutics Drugs Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Urological Cancer Therapeutics Drugs Players in Global Market
    3.2 Top Global Urological Cancer Therapeutics Drugs Companies Ranked by Revenue
    3.3 Global Urological Cancer Therapeutics Drugs Revenue by Companies
    3.4 Global Urological Cancer Therapeutics Drugs Sales by Companies
    3.5 Global Urological Cancer Therapeutics Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Urological Cancer Therapeutics Drugs Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Urological Cancer Therapeutics Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Urological Cancer Therapeutics Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Urological Cancer Therapeutics Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Urological Cancer Therapeutics Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Urological Cancer Therapeutics Drugs Market Size Markets, 2021 & 2027
        4.1.2 Xofigo (radium Ra 223 dichloride)
        4.1.3 Jevtana (cabazitaxel)
        4.1.4 Inlyta (axitinib)
        4.1.5 Votrient (pazopanib hydrochloride)
        4.1.6 Sutent (sunitinib malate)
        4.1.7 Zytiga (abiraterone acetate)
        4.1.8 Xtandi (enzalutamide)
        4.1.9 Opdivo (nivolumab)
        4.1.10 Provenge (sipuleucel-T)
    4.2 By Type - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
        4.2.1 By Type - Global Urological Cancer Therapeutics Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Urological Cancer Therapeutics Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    4.3 By Type - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
        4.3.1 By Type - Global Urological Cancer Therapeutics Drugs Sales, 2016-2021
        4.3.2 By Type - Global Urological Cancer Therapeutics Drugs Sales, 2022-2027
        4.3.3 By Type - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    4.4 By Type - Global Urological Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Urological Cancer Therapeutics Drugs Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Medical Research Laboratory
        5.1.4 Others
    5.2 By Application - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
        5.2.1 By Application - Global Urological Cancer Therapeutics Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Urological Cancer Therapeutics Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    5.3 By Application - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
        5.3.1 By Application - Global Urological Cancer Therapeutics Drugs Sales, 2016-2021
        5.3.2 By Application - Global Urological Cancer Therapeutics Drugs Sales, 2022-2027
        5.3.3 By Application - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    5.4 By Application - Global Urological Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Urological Cancer Therapeutics Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
        6.2.1 By Region - Global Urological Cancer Therapeutics Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Urological Cancer Therapeutics Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    6.3 By Region - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
        6.3.1 By Region - Global Urological Cancer Therapeutics Drugs Sales, 2016-2021
        6.3.2 By Region - Global Urological Cancer Therapeutics Drugs Sales, 2022-2027
        6.3.3 By Region - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Urological Cancer Therapeutics Drugs Revenue, 2016-2027
        6.4.2 By Country - North America Urological Cancer Therapeutics Drugs Sales, 2016-2027
        6.4.3 US Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.4.4 Canada Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.4.5 Mexico Urological Cancer Therapeutics Drugs Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Urological Cancer Therapeutics Drugs Revenue, 2016-2027
        6.5.2 By Country - Europe Urological Cancer Therapeutics Drugs Sales, 2016-2027
        6.5.3 Germany Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.4 France Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.5 U.K. Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.6 Italy Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.7 Russia Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.8 Nordic Countries Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.5.9 Benelux Urological Cancer Therapeutics Drugs Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Urological Cancer Therapeutics Drugs Revenue, 2016-2027
        6.6.2 By Region - Asia Urological Cancer Therapeutics Drugs Sales, 2016-2027
        6.6.3 China Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.6.4 Japan Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.6.5 South Korea Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.6.6 Southeast Asia Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.6.7 India Urological Cancer Therapeutics Drugs Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Urological Cancer Therapeutics Drugs Revenue, 2016-2027
        6.7.2 By Country - South America Urological Cancer Therapeutics Drugs Sales, 2016-2027
        6.7.3 Brazil Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.7.4 Argentina Urological Cancer Therapeutics Drugs Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Sales, 2016-2027
        6.8.3 Turkey Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.8.4 Israel Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.8.5 Saudi Arabia Urological Cancer Therapeutics Drugs Market Size, 2016-2027
        6.8.6 UAE Urological Cancer Therapeutics Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Novartis
        7.1.1 Novartis Corporate Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Urological Cancer Therapeutics Drugs Major Product Offerings
        7.1.4 Novartis Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.1.5 Novartis Key News
    7.2 Pfizer
        7.2.1 Pfizer Corporate Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Urological Cancer Therapeutics Drugs Major Product Offerings
        7.2.4 Pfizer Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.2.5 Pfizer Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Major Product Offerings
        7.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.3.5 Johnson & Johnson Key News
    7.4 AstraZeneca
        7.4.1 AstraZeneca Corporate Summary
        7.4.2 AstraZeneca Business Overview
        7.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Major Product Offerings
        7.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.4.5 AstraZeneca Key News
    7.5 Astellas
        7.5.1 Astellas Corporate Summary
        7.5.2 Astellas Business Overview
        7.5.3 Astellas Urological Cancer Therapeutics Drugs Major Product Offerings
        7.5.4 Astellas Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.5.5 Astellas Key News
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Corporate Summary
        7.6.2 Bristol-Myers Squibb Business Overview
        7.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Major Product Offerings
        7.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.6.5 Bristol-Myers Squibb Key News
    7.7 Abbott Laboratories
        7.7.1 Abbott Laboratories Corporate Summary
        7.7.2 Abbott Laboratories Business Overview
        7.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Major Product Offerings
        7.4.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.7.5 Abbott Laboratories Key News
    7.8 Celgene Corporation
        7.8.1 Celgene Corporation Corporate Summary
        7.8.2 Celgene Corporation Business Overview
        7.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Major Product Offerings
        7.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.8.5 Celgene Corporation Key News
    7.9 Dendreon Corporation
        7.9.1 Dendreon Corporation Corporate Summary
        7.9.2 Dendreon Corporation Business Overview
        7.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Major Product Offerings
        7.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.9.5 Dendreon Corporation Key News
    7.10 Ferring Pharmaceuticals
        7.10.1 Ferring Pharmaceuticals Corporate Summary
        7.10.2 Ferring Pharmaceuticals Business Overview
        7.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Major Product Offerings
        7.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.10.5 Ferring Pharmaceuticals Key News
    7.11 GlaxoSmithKline plc
        7.11.1 GlaxoSmithKline plc Corporate Summary
        7.11.2 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Business Overview
        7.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Major Product Offerings
        7.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.11.5 GlaxoSmithKline plc Key News
    7.12 Indevus Pharmaceuticals Inc
        7.12.1 Indevus Pharmaceuticals Inc Corporate Summary
        7.12.2 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Business Overview
        7.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Major Product Offerings
        7.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.12.5 Indevus Pharmaceuticals Inc Key News
    7.13 Ipsen
        7.13.1 Ipsen Corporate Summary
        7.13.2 Ipsen Urological Cancer Therapeutics Drugs Business Overview
        7.13.3 Ipsen Urological Cancer Therapeutics Drugs Major Product Offerings
        7.13.4 Ipsen Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.13.5 Ipsen Key News
    7.14 Roche Healthcare
        7.14.1 Roche Healthcare Corporate Summary
        7.14.2 Roche Healthcare Business Overview
        7.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Major Product Offerings
        7.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.14.5 Roche Healthcare Key News
    7.15 Sanofi S.A.
        7.15.1 Sanofi S.A. Corporate Summary
        7.15.2 Sanofi S.A. Business Overview
        7.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Major Product Offerings
        7.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2016-2021)
        7.15.5 Sanofi S.A. Key News
8 Global Urological Cancer Therapeutics Drugs Production Capacity, Analysis
    8.1 Global Urological Cancer Therapeutics Drugs Production Capacity, 2016-2027
    8.2 Urological Cancer Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Urological Cancer Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Urological Cancer Therapeutics Drugs Supply Chain Analysis
    10.1 Urological Cancer Therapeutics Drugs Industry Value Chain
    10.2 Urological Cancer Therapeutics Drugs Upstream Market
    10.3 Urological Cancer Therapeutics Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Urological Cancer Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Urological Cancer Therapeutics Drugs in Global Market
    Table 2. Top Urological Cancer Therapeutics Drugs Players in Global Market, Ranking by Revenue (2019)
    Table 3. Global Urological Cancer Therapeutics Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. Global Urological Cancer Therapeutics Drugs Revenue Share by Companies, 2016-2021
    Table 5. Global Urological Cancer Therapeutics Drugs Sales by Companies, (K MT), 2016-2021
    Table 6. Global Urological Cancer Therapeutics Drugs Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Urological Cancer Therapeutics Drugs Price (2016-2021) & (USD/MT)
    Table 8. Global Manufacturers Urological Cancer Therapeutics Drugs Product Type
    Table 9. List of Global Tier 1 Urological Cancer Therapeutics Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Urological Cancer Therapeutics Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2016-2021
    Table 13. By Type - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2022-2027
    Table 14. By Type - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2016-2021
    Table 15. By Type - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2022-2027
    Table 16. By Application – Global Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 17. By Application - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2016-2021
    Table 18. By Application - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2022-2027
    Table 19. By Application - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2016-2021
    Table 20. By Application - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2022-2027
    Table 21. By Region – Global Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 22. By Region - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2016-2021
    Table 23. By Region - Global Urological Cancer Therapeutics Drugs Revenue (US$, Mn), 2022-2027
    Table 24. By Region - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2016-2021
    Table 25. By Region - Global Urological Cancer Therapeutics Drugs Sales (K MT), 2022-2027
    Table 26. By Country - North America Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - North America Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - North America Urological Cancer Therapeutics Drugs Sales, (K MT), 2016-2021
    Table 29. By Country - North America Urological Cancer Therapeutics Drugs Sales, (K MT), 2022-2027
    Table 30. By Country - Europe Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2021
    Table 31. By Country - Europe Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022-2027
    Table 32. By Country - Europe Urological Cancer Therapeutics Drugs Sales, (K MT), 2016-2021
    Table 33. By Country - Europe Urological Cancer Therapeutics Drugs Sales, (K MT), 2022-2027
    Table 34. By Region - Asia Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2021
    Table 35. By Region - Asia Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022-2027
    Table 36. By Region - Asia Urological Cancer Therapeutics Drugs Sales, (K MT), 2016-2021
    Table 37. By Region - Asia Urological Cancer Therapeutics Drugs Sales, (K MT), 2022-2027
    Table 38. By Country - South America Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2021
    Table 39. By Country - South America Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022-2027
    Table 40. By Country - South America Urological Cancer Therapeutics Drugs Sales, (K MT), 2016-2021
    Table 41. By Country - South America Urological Cancer Therapeutics Drugs Sales, (K MT), 2022-2027
    Table 42. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2021
    Table 43. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022-2027
    Table 44. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Sales, (K MT), 2016-2021
    Table 45. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Sales, (K MT), 2022-2027
    Table 46. Novartis Corporate Summary
    Table 47. Novartis Urological Cancer Therapeutics Drugs Product Offerings
    Table 48. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 49. Pfizer Corporate Summary
    Table 50. Pfizer Urological Cancer Therapeutics Drugs Product Offerings
    Table 51. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 52. Johnson & Johnson Corporate Summary
    Table 53. Johnson & Johnson Urological Cancer Therapeutics Drugs Product Offerings
    Table 54. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 55. AstraZeneca Corporate Summary
    Table 56. AstraZeneca Urological Cancer Therapeutics Drugs Product Offerings
    Table 57. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 58. Astellas Corporate Summary
    Table 59. Astellas Urological Cancer Therapeutics Drugs Product Offerings
    Table 60. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 61. Bristol-Myers Squibb Corporate Summary
    Table 62. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Offerings
    Table 63. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 64. Abbott Laboratories Corporate Summary
    Table 65. Abbott Laboratories Urological Cancer Therapeutics Drugs Product Offerings
    Table 66. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 67. Celgene Corporation Corporate Summary
    Table 68. Celgene Corporation Urological Cancer Therapeutics Drugs Product Offerings
    Table 69. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 70. Dendreon Corporation Corporate Summary
    Table 71. Dendreon Corporation Urological Cancer Therapeutics Drugs Product Offerings
    Table 72. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 73. Ferring Pharmaceuticals Corporate Summary
    Table 74. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Offerings
    Table 75. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 76. GlaxoSmithKline plc Corporate Summary
    Table 77. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product Offerings
    Table 78. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 79. Indevus Pharmaceuticals Inc Corporate Summary
    Table 80. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product Offerings
    Table 81. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 82. Ipsen Corporate Summary
    Table 83. Ipsen Urological Cancer Therapeutics Drugs Product Offerings
    Table 84. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 85. Roche Healthcare Corporate Summary
    Table 86. Roche Healthcare Urological Cancer Therapeutics Drugs Product Offerings
    Table 87. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 88. Sanofi S.A. Corporate Summary
    Table 89. Sanofi S.A. Urological Cancer Therapeutics Drugs Product Offerings
    Table 90. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
    Table 91. Urological Cancer Therapeutics Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
    Table 92. Global Urological Cancer Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2019-2021
    Table 93. Global Urological Cancer Therapeutics Drugs Production by Region, 2016-2021 (K MT)
    Table 94. Global Urological Cancer Therapeutics Drugs Production by Region, 2022-2027 (K MT)
    Table 95. Urological Cancer Therapeutics Drugs Market Opportunities & Trends in Global Market
    Table 96. Urological Cancer Therapeutics Drugs Market Drivers in Global Market
    Table 97. Urological Cancer Therapeutics Drugs Market Restraints in Global Market
    Table 98. Urological Cancer Therapeutics Drugs Raw Materials
    Table 99. Urological Cancer Therapeutics Drugs Raw Materials Suppliers in Global Market
    Table 100. Typical Urological Cancer Therapeutics Drugs Downstream
    Table 101. Urological Cancer Therapeutics Drugs Downstream Clients in Global Market
    Table 102. Urological Cancer Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Urological Cancer Therapeutics Drugs Segment by Type
    Figure 2. Urological Cancer Therapeutics Drugs Segment by Application
    Figure 3. Global Urological Cancer Therapeutics Drugs Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Urological Cancer Therapeutics Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Urological Cancer Therapeutics Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. Urological Cancer Therapeutics Drugs Sales in Global Market: 2016-2027 (K MT)
    Figure 8. The Top 3 and 5 Players Market Share by Urological Cancer Therapeutics Drugs Revenue in 2020
    Figure 9. By Type - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 10. By Type - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 11. By Type - Global Urological Cancer Therapeutics Drugs Price (USD/MT), 2016-2027
    Figure 12. By Application - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 13. By Application - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 14. By Application - Global Urological Cancer Therapeutics Drugs Price (USD/MT), 2016-2027
    Figure 15. By Region - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 16. By Region - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 17. By Country - North America Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 18. By Country - North America Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 19. US Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 20. Canada Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 21. Mexico Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 22. By Country - Europe Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 23. By Country - Europe Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 24. Germany Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 25. France Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 26. U.K. Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 27. Italy Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 28. Russia Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 29. Nordic Countries Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 30. Benelux Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 31. By Region - Asia Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 32. By Region - Asia Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 33. China Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 34. Japan Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 35. South Korea Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 36. Southeast Asia Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 37. India Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 38. By Country - South America Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 39. By Country - South America Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 40. Brazil Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 41. Argentina Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 42. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Revenue Market Share, 2016-2027
    Figure 43. By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Sales Market Share, 2016-2027
    Figure 44. Turkey Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 45. Israel Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 46. Saudi Arabia Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 47. UAE Urological Cancer Therapeutics Drugs Revenue, (US$, Mn), 2016-2027
    Figure 48. Global Urological Cancer Therapeutics Drugs Production Capacity (K MT), 2016-2027
    Figure 49. The Percentage of Production Urological Cancer Therapeutics Drugs by Region, 2020 VS 2027
    Figure 50. Urological Cancer Therapeutics Drugs Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Urological Cancer Therapeutics Drugs Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Urological Cancer Therapeutics Drugs Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Urological Cancer Therapeutics Drugs Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports